Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Fostipur (urofollitropin) vs Meriofert (menotropin) in women with polycystic ovaries undergoing IVF/ICSI
2015-005660-42Phase 4Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in polycystic ovary syndrome (PCOS) comparing Fostipur arm with Meriofert arm (2 arms). Primary endpoint: Quantity of mature oocytes relative to total oocytes retrieved. Started Mar 2016; status: terminated.
02
Drugs
urofollitropinhuman menopausal gonadotrophin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2015-005660-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005660-42.